Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PTNS vs Desmopressin in PMNE
NCT04545931Phase 4Unknown
- Sponsor
- Cairo University
- Start
- Mar 2020
- Primary completion
- Nov 2020
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (2 arms), sponsored by Cairo University. Primary endpoint: Frequency of nocturnal enuresis at 16 weeks. Status: unknown.
Beyond the preview
Go deeper on NCT04545931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04545931.